These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 29430824)

  • 1. DNA methylation analyses of the candidate genes identified by a methylome-wide association study revealed common epigenetic alterations in schizophrenia and bipolar disorder.
    Sugawara H; Murata Y; Ikegame T; Sawamura R; Shimanaga S; Takeoka Y; Saito T; Ikeda M; Yoshikawa A; Nishimura F; Kawamura Y; Kakiuchi C; Sasaki T; Iwata N; Hashimoto M; Kasai K; Kato T; Bundo M; Iwamoto K
    Psychiatry Clin Neurosci; 2018 Apr; 72(4):245-254. PubMed ID: 29430824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypomethylation of FAM63B in bipolar disorder patients.
    Starnawska A; Demontis D; McQuillin A; O'Brien NL; Staunstrup NH; Mors O; Nielsen AL; Børglum AD; Nyegaard M
    Clin Epigenetics; 2016; 8():52. PubMed ID: 27175219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide methylome analyses reveal novel epigenetic regulation patterns in schizophrenia and bipolar disorder.
    Li Y; Camarillo C; Xu J; Arana TB; Xiao Y; Zhao Z; Chen H; Ramirez M; Zavala J; Escamilla MA; Armas R; Mendoza R; Ontiveros A; Nicolini H; Magaña AA; Rubin LP; Li X; Xu C
    Biomed Res Int; 2015; 2015():201587. PubMed ID: 25734057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivation of poly-methylomic profile scores for schizophrenia.
    Watkeys OJ; Cohen-Woods S; Quidé Y; Cairns MJ; Overs B; Fullerton JM; Green MJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jul; 101():109925. PubMed ID: 32194204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder.
    Dempster EL; Pidsley R; Schalkwyk LC; Owens S; Georgiades A; Kane F; Kalidindi S; Picchioni M; Kravariti E; Toulopoulou T; Murray RM; Mill J
    Hum Mol Genet; 2011 Dec; 20(24):4786-96. PubMed ID: 21908516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter Activity-Based Case-Control Association Study on SLC6A4 Highlighting Hypermethylation and Altered Amygdala Volume in Male Patients With Schizophrenia.
    Ikegame T; Bundo M; Okada N; Murata Y; Koike S; Sugawara H; Saito T; Ikeda M; Owada K; Fukunaga M; Yamashita F; Koshiyama D; Natsubori T; Iwashiro N; Asai T; Yoshikawa A; Nishimura F; Kawamura Y; Ishigooka J; Kakiuchi C; Sasaki T; Abe O; Hashimoto R; Iwata N; Yamasue H; Kato T; Kasai K; Iwamoto K
    Schizophr Bull; 2020 Dec; 46(6):1577-1586. PubMed ID: 32556264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide DNA methylation risk scores for schizophrenia derived from blood and brain tissues further explain the genetic risk in patients stratified by polygenic risk scores for schizophrenia and bipolar disorder.
    Ohi K; Shimada M; Soda M; Nishizawa D; Fujikane D; Takai K; Kuramitsu A; Muto Y; Sugiyama S; Hasegawa J; Kitaichi K; Ikeda K; Shioiri T
    BMJ Ment Health; 2024 Jan; 27(1):. PubMed ID: 38216218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clues in solving the mystery of major psychosis: The epigenetic basis of schizophrenia and bipolar disorder.
    Gürel Ç; Kuşçu GC; Yavaşoğlu A; Biray Avcı Ç
    Neurosci Biobehav Rev; 2020 Jun; 113():51-61. PubMed ID: 32147531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic drugs attenuate aberrant DNA methylation of DTNBP1 (dysbindin) promoter in saliva and post-mortem brain of patients with schizophrenia and Psychotic bipolar disorder.
    Abdolmaleky HM; Pajouhanfar S; Faghankhani M; Joghataei MT; Mostafavi A; Thiagalingam S
    Am J Med Genet B Neuropsychiatr Genet; 2015 Dec; 168(8):687-96. PubMed ID: 26285059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant transcriptomes and DNA methylomes define pathways that drive pathogenesis and loss of brain laterality/asymmetry in schizophrenia and bipolar disorder.
    Abdolmaleky HM; Gower AC; Wong CK; Cox JW; Zhang X; Thiagalingam A; Shafa R; Sivaraman V; Zhou JR; Thiagalingam S
    Am J Med Genet B Neuropsychiatr Genet; 2019 Mar; 180(2):138-149. PubMed ID: 30468562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BDgene: a genetic database for bipolar disorder and its overlap with schizophrenia and major depressive disorder.
    Chang SH; Gao L; Li Z; Zhang WN; Du Y; Wang J
    Biol Psychiatry; 2013 Nov; 74(10):727-33. PubMed ID: 23764453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of DNA Methylation Differences With Schizophrenia in an Epigenome-Wide Association Study.
    Montano C; Taub MA; Jaffe A; Briem E; Feinberg JI; Trygvadottir R; Idrizi A; Runarsson A; Berndsen B; Gur RC; Moore TM; Perry RT; Fugman D; Sabunciyan S; Yolken RH; Hyde TM; Kleinman JE; Sobell JL; Pato CN; Pato MT; Go RC; Nimgaonkar V; Weinberger DR; Braff D; Gur RE; Fallin MD; Feinberg AP
    JAMA Psychiatry; 2016 May; 73(5):506-14. PubMed ID: 27074206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multimodal attempt to follow-up linkage regions using RNA expression, SNPs and CpG methylation in schizophrenia and bipolar disorder kindreds.
    Chagnon YC; Maziade M; Paccalet T; Croteau J; Fournier A; Roy MA; Bureau A
    Eur J Hum Genet; 2020 Apr; 28(4):499-507. PubMed ID: 31695175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of schizophrenia-associated loci by combining DNA methylation and gene expression data from whole blood.
    van Eijk KR; de Jong S; Strengman E; Buizer-Voskamp JE; Kahn RS; Boks MP; Horvath S; Ophoff RA
    Eur J Hum Genet; 2015 Aug; 23(8):1106-10. PubMed ID: 25424713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentially methylated regions in bipolar disorder and suicide.
    Gaine ME; Seifuddin F; Sabunciyan S; Lee RS; Benke KS; Monson ET; Zandi PP; Potash JB; Willour VL
    Am J Med Genet B Neuropsychiatr Genet; 2019 Oct; 180(7):496-507. PubMed ID: 31350827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study on commonality and specificity of copy number variants in schizophrenia and bipolar disorder.
    Chen J; Calhoun VD; Perrone-Bizzozero NI; Pearlson GD; Sui J; Du Y; Liu J
    Transl Psychiatry; 2016 May; 6(5):e824. PubMed ID: 27244233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do schizophrenia and bipolar disorders share a common disease susceptibility variant at the MMP3 gene?
    Kucukali CI; Aydin M; Ozkok E; Bilge E; Orhan N; Zengin A; Kara I
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):557-61. PubMed ID: 19245826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA hypermethylation of serotonin transporter gene promoter in drug naïve patients with schizophrenia.
    Abdolmaleky HM; Nohesara S; Ghadirivasfi M; Lambert AW; Ahmadkhaniha H; Ozturk S; Wong CK; Shafa R; Mostafavi A; Thiagalingam S
    Schizophr Res; 2014 Feb; 152(2-3):373-80. PubMed ID: 24411530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo CNVs in bipolar affective disorder and schizophrenia.
    Georgieva L; Rees E; Moran JL; Chambert KD; Milanova V; Craddock N; Purcell S; Sklar P; McCarroll S; Holmans P; O'Donovan MC; Owen MJ; Kirov G
    Hum Mol Genet; 2014 Dec; 23(24):6677-83. PubMed ID: 25055870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of a Reproducible Epigenetic Risk Profile for Schizophrenia With Brain Methylation and Function.
    Chen J; Zang Z; Braun U; Schwarz K; Harneit A; Kremer T; Ma R; Schweiger J; Moessnang C; Geiger L; Cao H; Degenhardt F; Nöthen MM; Tost H; Meyer-Lindenberg A; Schwarz E
    JAMA Psychiatry; 2020 Jun; 77(6):628-636. PubMed ID: 32049268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.